Skip to main content

Procedures for Mucosal Immunization and Analyses of Cellular Immune Response to Candidate HIV Vaccines in Murine and Nonhuman Primate Models

  • Protocol
  • First Online:
Immunoinformatics

Abstract

Sampling the mucosal tissues and analyses of immune responses are integral to vaccine-development strategies against human immunodeficiency virus (HIV), which is transmitted predominantly across the oro-genital mucosa. While immune assay development and standardization attempts employ mouse models, immunogenicity and protective efficacy that can be extrapolated to humans are realized only from experiments in nonhuman primates. Here, we describe commonly used practices for immunizations in rhesus macaques (Macaca mulatta) along with procedures for obtaining important mucosal tissues samples from macaques and mice. We also describe detailed protocols for two important assays applicable in mouse as well as primate experiments for determining antigen-specific T cells responses induced after vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gamble LJ, Matthews QL (2010) Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther 5:9–26

    PubMed Central  PubMed  Google Scholar 

  2. Girard MP, Osmanov SK, Kieny MP (2006) A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 19:4062–4081

    Article  Google Scholar 

  3. Kim JH, Rerks-Ngarm S, Excler JL et al (2010) HIV vaccines: lessons learned and the way forward. Curr Opin HIV AIDS 5:428–3

    Article  PubMed Central  PubMed  Google Scholar 

  4. Esparza J, Osmanov S (2003) HIV vaccines: a global perspective. Curr Mol Med 3:183–193

    Article  CAS  PubMed  Google Scholar 

  5. Hu SL (2005) Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 2:193–201

    Article  Google Scholar 

  6. Duerr A (2010) Update on mucosal HIV vaccine vectors. Curr Opin HIV AIDS 5:397–403

    Article  PubMed  Google Scholar 

  7. Nehete PN, Singh S, Sastry KJ (2013) Lessons on non-progression of HIV disease from monkeys. Front Immunol 4:64

    Article  PubMed Central  PubMed  Google Scholar 

  8. Nehete PN, Nehete BP, Hill L et al (2008) Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Virology 370:130–141

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Sastry KJ, Nehete PN, Venkatnarayanan S et al (1992) Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120. Virology 188:502–509

    Article  CAS  PubMed  Google Scholar 

  10. Weaver EA, Nehete PN, Nehete BP et al (2009) Protection against mucosal SHIV challenge by peptide and helper-dependent adenovirus vaccines. Viruses 1:920

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Murphy KL, Baxter MG, Flecknell PA (2012) Anesthesia and analgesia in nonhuman primates. In: Abee CR, Mansfield K, Tardif SD et al (eds) Nonhuman primates in biomedical research: biology and management. Academic, San Diego, CA, pp 403–436

    Chapter  Google Scholar 

  12. Popilskis SJ, Lee DR, Elmore DB (2011) Anesthesia and analgesia in nonhuman primates. In: Fish R, Danneman PJ, Brown M, Karas A (eds) Anesthesia and analgesia in laboratory animals. Academic, San Diego, CA, pp 335–363

    Google Scholar 

  13. Bellanti JA, Zeligs BJ, Mendez de Inocencio J et al (2001) Alternative routes of immunization for prevention of infectious diseases: a new paradigm for the 21st century. Allergy Asthma Proc 22:173–176

    Article  CAS  PubMed  Google Scholar 

  14. Scherliess R (2011) Delivery of antigens used for vaccination: recent advances and challenges. Ther Deliv 2:1351–1368

    Article  CAS  PubMed  Google Scholar 

  15. Meeusen EN (2011) Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 29:8506–8511

    Article  CAS  PubMed  Google Scholar 

  16. Demberg T, Robert-Guroff M (2009) Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol 28:20–48

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Pachuk CJ, McCallus DE, Weiner DB, Satishchandran C (2000) DNA vaccines—challenges in delivery. Curr Opin Mol Ther 2:188–189

    CAS  PubMed  Google Scholar 

  18. Dunn TB (1954) Normal and pathological anatomy of the reticular tissue in laboratory mice. J Natl Cancer Inst 14:1281–1434

    CAS  PubMed  Google Scholar 

  19. Covelli V (2013) Guide to the necropsy of the mouse. http://eulep.pdn.cam.ac.uk/Necropsy_of_the_Mouse. Accessed 28 July 2013

  20. Reeves JP, Reeves PA (2001) Removal of lymphoid organs. Curr Protoc Immunol 1:1.9.1–1.9.3

    Google Scholar 

  21. Fuss IJ, Kanof ME, Smith PD, Zola H (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol 85:7.1.1–7.1.8

    Google Scholar 

  22. Ulmer AJ, Scholz W, Ernst M et al (1984) Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology 166:238–250

    Article  CAS  PubMed  Google Scholar 

  23. Schluns KS, Nowak EC, Cabrera-Hernandez A et al (2004) Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression. Proc Natl Acad Sci U S A 101:5616–5621

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Sheridan BS, Lefrançois L (2012) Isolation of mouse lymphocytes from small intestine tissues. Curr Protoc Immunol 99:3.19.1–3.19.11

    Google Scholar 

  25. Seifter S, Gallop PM, Klein L et al (1959) Studies on collagen, part II. Properties of purified collagenase and its inhibition. J Biol Chem 234:285

    CAS  PubMed  Google Scholar 

  26. Koup RA, Douek DC (2011) Vaccine design for CD8 T lymphocyte responses. Cold Spring Harb Perspect Med 1(1):a007252. doi:10.1101/cshperspect.a007252

    Article  PubMed Central  PubMed  Google Scholar 

  27. Appay V, Douek DC, Price DA (2008) CD8+ T cell efficacy in vaccination and disease. Nat Med 14:623–628

    Article  CAS  PubMed  Google Scholar 

  28. Swain SL, McKinstry KK, Strutt TM (2012) Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol 12:136–148

    CAS  PubMed Central  PubMed  Google Scholar 

  29. Perrin H, Canderan G, Sékaly RP, Trautmann L (2010) New approaches to design HIV-1T-cell vaccines. Curr Opin HIV AIDS 5:368–376

    Article  PubMed  Google Scholar 

  30. Schmittel A, Keilholz U, Thiel E, Scheibenbogen C (2000) Quantification of tumor-specific T lymphocytes with the ELISPOT assay. J Immunother 23:289–295

    Article  CAS  PubMed  Google Scholar 

  31. De Rosa SC (2012) Vaccine applications of flow cytometry. Methods 57:383–391

    Article  PubMed Central  PubMed  Google Scholar 

  32. Lehmann PV, Zhang W (2012) Unique strengths of ELISPOT for T cell diagnostics. Methods Mol Biol 792:3–23

    Article  CAS  PubMed  Google Scholar 

  33. Kalyuzhny AE (2005) Chemistry and biology of the ELISPOT assay. In: Kalyuzhny AE (ed) Handbook of ELISPOT: methods and protocols. Humana Press, Totowa, pp 15–31

    Chapter  Google Scholar 

  34. Lehman PV (2005) Image analysis and data management of ELISPOT assay results. In: Kalyuzhny AE (ed) Handbook of ELISPOT: methods and protocols. Humana Press, Totowa, pp 117–132

    Chapter  Google Scholar 

  35. Weaver EA, Nehete PN, Nehete BP et al (2013) Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One 8(7):e67574. doi:10.1371/journal.pone.0067574

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Smith SG, Joosten SA, Verscheure V et al (2009) Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4(11):e7972. doi:10.1371/journal.pone.0007972

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Jagannadha Sastry .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Singh, S. et al. (2014). Procedures for Mucosal Immunization and Analyses of Cellular Immune Response to Candidate HIV Vaccines in Murine and Nonhuman Primate Models. In: De, R., Tomar, N. (eds) Immunoinformatics. Methods in Molecular Biology, vol 1184. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1115-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1115-8_24

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1114-1

  • Online ISBN: 978-1-4939-1115-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics